Updated Jul 16, 2026
PATIENCE JOHN has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $418K.
John Patience is a corporate director known for his involvement with companies in the diagnostics and biotechnology sectors, including Accelerate Diagnostics, Inc. and Biodesix Inc. His experience spans various roles in corporate governance and strategy.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | BDSX | BIODESIX INC | M — Option exercise | 1.4K | — | |
| 2026-04-02 | BDSX | BIODESIX INC | M — Option exercise | 1.4K | — | |
| 2026-01-06 | BDSX | BIODESIX INC | M — Option exercise | 1.1K | — | |
| 2025-09-30 | BDSX | BIODESIX INC | M — Option exercise | 1.1K | — | |
| 2025-06-30 | BDSX | BIODESIX INC | M — Option exercise | 22.9K | — | |
| 2025-03-31 | BDSX | BIODESIX INC | M — Option exercise | 46.7K | — | |
| 2024-12-03 | AXDX | Accelerate Diagnostics, Inc | P — Open-market purchase | 200.0K | $1.57 | $314K |
| 2024-11-06 | BDSX | BIODESIX INC | P — Open-market purchase | 75.0K | $1.38 | $104K |
John Patience is a corporate director known for his involvement with companies in the diagnostics and biotechnology sectors, including Accelerate Diagnostics, Inc. and Biodesix Inc. His experience spans various roles in corporate governance and strategy.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($418K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PATIENCE JOHN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.